Genine Winslow

Founder, CEO & Board President

Genine founded Chameleon Biosciences in 2017 to provide next-generation gene therapies to treat more patients with rare genetic diseases.

Prior to founding Chameleon, Ms. Winslow was the Director of Analytics at Audentes Therapeutics which focused on developing gene therapies for Myotubular Myopathy, Pompe Disease, and CASQ2-related Catecholami...


Roles at Chameleon Biosciences

  • Founder, CEO & Board President

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Chameleon Biosciences

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.